ATE471152T1 - Anti-adhäsives agens für die pathogene hautflora - Google Patents

Anti-adhäsives agens für die pathogene hautflora

Info

Publication number
ATE471152T1
ATE471152T1 AT00990751T AT00990751T ATE471152T1 AT E471152 T1 ATE471152 T1 AT E471152T1 AT 00990751 T AT00990751 T AT 00990751T AT 00990751 T AT00990751 T AT 00990751T AT E471152 T1 ATE471152 T1 AT E471152T1
Authority
AT
Austria
Prior art keywords
adhesive agent
skin flora
pathogenic skin
pathogenic
flora
Prior art date
Application number
AT00990751T
Other languages
English (en)
Inventor
Markus Baur
Ralf Zink
Isabelle Auzanneau
Karine Buffard
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Application granted granted Critical
Publication of ATE471152T1 publication Critical patent/ATE471152T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/005—Preparations for sensitive skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/008—Preparations for oily skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Birds (AREA)
  • Zoology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT00990751T 1999-12-22 2000-12-13 Anti-adhäsives agens für die pathogene hautflora ATE471152T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99204489A EP1110555A1 (de) 1999-12-22 1999-12-22 Anti-adhäsives Agens für die pathogene Hautflora
PCT/EP2000/012719 WO2001045721A1 (fr) 1999-12-22 2000-12-13 Agent anti-adhesion de la flore pathogene de la peau

Publications (1)

Publication Number Publication Date
ATE471152T1 true ATE471152T1 (de) 2010-07-15

Family

ID=8241061

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00990751T ATE471152T1 (de) 1999-12-22 2000-12-13 Anti-adhäsives agens für die pathogene hautflora

Country Status (20)

Country Link
US (4) US20030049231A1 (de)
EP (2) EP1110555A1 (de)
JP (1) JP4828759B2 (de)
KR (1) KR100797819B1 (de)
CN (2) CN101385745B (de)
AR (1) AR030925A1 (de)
AT (1) ATE471152T1 (de)
AU (1) AU3011801A (de)
BR (1) BR0016709A (de)
CA (1) CA2395419C (de)
CY (1) CY1111029T1 (de)
DE (1) DE60044566D1 (de)
DK (1) DK1244463T3 (de)
ES (1) ES2345761T3 (de)
MX (1) MXPA02006222A (de)
NO (1) NO20022989L (de)
PL (1) PL355411A1 (de)
PT (1) PT1244463E (de)
RU (1) RU2002119396A (de)
WO (1) WO2001045721A1 (de)

Families Citing this family (99)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0124580D0 (en) * 2001-10-12 2001-12-05 Univ Reading New composition
PT1478329E (pt) * 2002-02-21 2006-09-29 Nestle Sa Composicao administravel por via oral para fotoproteccao da pele
WO2003084989A2 (en) * 2002-04-09 2003-10-16 Societe Des Produits Nestle S.A. La1 - the genome of a lactobacillus strain
FR2844198A1 (fr) * 2002-09-06 2004-03-12 Oreal Utilisation d'un activeur de protectin pour ameliorer la resistance de la peau, composition contenant de tels activateurs et procede de selection
DE102004023612A1 (de) * 2004-05-10 2005-12-01 Helmut Meusel Verwendung von microbiellen Mischbiozönosen zur Behandlung von Entzündungen der Haut
JP2008503563A (ja) * 2004-06-23 2008-02-07 ロレアル 敏感及び／又は乾燥肌の予防及び／又は処置に有用な方法及び組成物
FR2872047B1 (fr) * 2004-06-23 2007-06-15 Oreal Composition pour peaux sensibles associant cation mineral et probiotique(s)
ITMI20041550A1 (it) * 2004-07-29 2004-10-29 Proge Farm Srl Uso di batteri probiotici per la preparazione di composizioni topiche per la protezione dell'epidermide
AU2005291098B2 (en) * 2004-10-04 2011-11-24 L'oreal Cosmetic and/or dermatological composition for sensitive skins
EP1731137A1 (de) * 2005-06-08 2006-12-13 Nestec S.A. Kosmetische oder dermatologische Zusammensetzung gegen trockene und/oder empfindliche Haut
EP1642570A1 (de) 2004-10-04 2006-04-05 L'oreal Kosmetische oder dermatologische Zusammensetzung gegen trockene und/oder empfindliche Haut
JP2005139198A (ja) * 2004-12-11 2005-06-02 Koichi Takezaki 抑臭効果を付加した生活関連商品
FR2879452B1 (fr) * 2004-12-21 2007-07-06 Oreal Utilisation d'un extrait de bacterie filamenteuse non photosynthetique non fructifiante en tant qu'agent modulant l'adhesion de microorganismes cutanes
JP4726109B2 (ja) * 2005-02-10 2011-07-20 昭和電工株式会社 皮膚外用剤、それを用いる皮膚有害微生物の付着予防方法及び増殖防止方法
FR2889057B1 (fr) * 2005-08-01 2008-07-18 Oreal Composition cosmetique et/ou dermatologique pour la prevention et/ou le traitement des peaux sensibles ou seches
JP5020245B2 (ja) * 2005-09-19 2012-09-05 ビーエーエスエフ ソシエタス・ヨーロピア 足臭の形成を阻害する微生物
EP1917960A1 (de) 2006-11-06 2008-05-07 Nestec S.A. Verbesserte biologische Effekte von Rosmarinsäure
FR2915388B1 (fr) * 2007-04-27 2010-12-24 Oreal Film hydrosoluble cosmetique
FR2919501B1 (fr) * 2007-08-02 2010-12-31 Oreal Utilisation d'hesperidine ou de l'un de ses derives pour la prevention et/ou le traitement des peaux relachees
BRPI0816214B8 (pt) * 2007-09-04 2017-12-26 Oreal uso cosmético, composição cosmética e/ou dermatológica, e, métodos para o tratamento cosmético da pele, para o tratamento cosmético de sinais cutâneos de envelhecimento e/ou fotoenvelhecimento e para o tratamento cosmético para prevenir e/ou tratar substâncias queratinosas secas
FR2920304B1 (fr) * 2007-09-04 2010-06-25 Oreal Utilisation cosmetique de lysat bifidobacterium species pour le traitement de la secheresse.
FR2920305B1 (fr) 2007-09-04 2010-07-30 Oreal Utilisation d'un lysat de bifidobacterium species pour le traitement de peaux sensibles.
FR2930443B1 (fr) 2008-04-29 2010-06-25 Oreal Produit extemporane de soin a base d'un lyophilisat de microorganisme et de tensioactif(s) de hlb superieur ou egal a 12
BRPI0916690B1 (pt) * 2008-07-29 2022-04-12 L'oreal Uso de uma quantidade eficaz de pelo menos um microorganismo probiótico, composição coméstica e/ou dermatólogica, método coméstico para tratar e/ou prevenir distúrbios estéticos do couro cabeludo em um indivíduo, processo cosmético para prevenir e/ou tratar uma condição de caspa do couro cabeludo, conjunto cosmético, e, uso cosmético de pelo menos uma quantidade eficaz de pelo menos um primeiro e um segundo agente cosmético ativo
FR2938437B1 (fr) * 2008-11-19 2020-03-27 Société des Produits Nestlé S.A. Utilisation cosmetique de microorganisme pour le traitement des peaux grasses
FR2945944B1 (fr) * 2009-06-02 2011-07-15 Oreal Procede cosmetique de traitement des etats pelliculaires comprenant l'administration d'un microorganisme probiotique et d'un actif antipelliculaire
FR2938429B1 (fr) * 2008-11-19 2012-05-18 Oreal Utilisation cosmetique de microorganisme(s) pour le traitement des desordres du cuir chevelu
US20100055082A1 (en) * 2008-09-04 2010-03-04 Jacques Alain Bauer Immunomodulatory extracts from lactobacillus bacteria and methods of manufacturing and use thereof
EP2161329A1 (de) * 2008-09-04 2010-03-10 OM Pharma Immunmodulierende Extrakte von Lactobacillus-Bakterien und Herstellungsverfahren und deren Verwendung
FR2937536B1 (fr) * 2008-10-28 2016-07-01 Oreal Utilisation cosmetique d'un lysat de bifidobacterium species pour le traitement du cuir chevelu gras
FR2937547B1 (fr) * 2008-10-28 2012-11-09 Oreal Utilisation d'un lysat de microorganisme pour le traitement des peaux grasses
FR2942719B1 (fr) 2009-03-04 2011-08-19 Oreal Utilisation de microorganismes probiotiques pour limiter les irritations cutanees
AU2010247469B2 (en) * 2009-05-11 2014-12-18 Société des Produits Nestlé S.A. Lactobacillus johnsonii La1 NCC533 (CNCM I-1225) and immune disorders
EP2251022A1 (de) * 2009-05-11 2010-11-17 Nestec S.A. Nicht-replizierte Mikroorganismen und deren immunstärkender Effekt
EP2251020A1 (de) * 2009-05-11 2010-11-17 Nestec S.A. Kurzzeitige Hochtemperaturbehandlung erzeugt mikrobielle Zubereitungen mit entzündungshemmenden Profilen
GB2472790A (en) * 2009-08-18 2011-02-23 Laurence Christian Hayes Dermatological preparations comprising microbes.
PL2364712T3 (pl) * 2010-03-11 2013-08-30 Kloarys Invest Ltd Miejscowa kompozycja kosmetyczna lub farmaceutyczna zawierająca probiotyczne szczepy pałeczek bakterii kwasu mlekowego i jej stosowanie
FR2959128B1 (fr) * 2010-04-23 2012-07-13 Oreal Utilisation cosmetique d'un lysat de bifidobacterium species pour le traitement des odeurs corporelles
DE102011009798B4 (de) * 2011-01-31 2015-03-05 Merz Pharma Gmbh & Co. Kgaa Balneologische lipidhaltige probiotische Zubereitungen für kosmetische / dermatologische / medizinische Anwendungen
US11357722B2 (en) 2011-02-04 2022-06-14 Seed Health, Inc. Method and system for preventing sore throat in humans
US10583033B2 (en) 2011-02-04 2020-03-10 Katherine Rose Kovarik Method and system for reducing the likelihood of a porphyromonas gingivalis infection in a human being
US10085938B2 (en) 2011-02-04 2018-10-02 Joseph E. Kovarik Method and system for preventing sore throat in humans
US11998479B2 (en) 2011-02-04 2024-06-04 Seed Health, Inc. Method and system for addressing adverse effects on the oral microbiome and restoring gingival health caused by sodium lauryl sulphate exposure
US11951140B2 (en) 2011-02-04 2024-04-09 Seed Health, Inc. Modulation of an individual's gut microbiome to address osteoporosis and bone disease
US10842834B2 (en) 2016-01-06 2020-11-24 Joseph E. Kovarik Method and system for reducing the likelihood of developing liver cancer in an individual diagnosed with non-alcoholic fatty liver disease
US10835560B2 (en) 2013-12-20 2020-11-17 Joseph E. Kovarik Reducing the likelihood of skin cancer in an individual human being
US11951139B2 (en) 2015-11-30 2024-04-09 Seed Health, Inc. Method and system for reducing the likelihood of osteoporosis
US10512661B2 (en) 2011-02-04 2019-12-24 Joseph E. Kovarik Method and system for reducing the likelihood of developing liver cancer in an individual diagnosed with non-alcoholic fatty liver disease
US10245288B2 (en) 2011-02-04 2019-04-02 Joseph E. Kovarik Method and system for reducing the likelihood of developing NASH in an individual diagnosed with non-alcoholic fatty liver disease
US10086018B2 (en) 2011-02-04 2018-10-02 Joseph E. Kovarik Method and system for reducing the likelihood of colorectal cancer in a human being
US10940169B2 (en) 2015-11-30 2021-03-09 Joseph E. Kovarik Method for reducing the likelihood of developing cancer in an individual human being
US10687975B2 (en) 2011-02-04 2020-06-23 Joseph E. Kovarik Method and system to facilitate the growth of desired bacteria in a human's mouth
US9987224B2 (en) 2011-02-04 2018-06-05 Joseph E. Kovarik Method and system for preventing migraine headaches, cluster headaches and dizziness
US11419903B2 (en) 2015-11-30 2022-08-23 Seed Health, Inc. Method and system for reducing the likelihood of osteoporosis
US11523934B2 (en) 2011-02-04 2022-12-13 Seed Health, Inc. Method and system to facilitate the growth of desired bacteria in a human's mouth
US11273187B2 (en) 2015-11-30 2022-03-15 Joseph E. Kovarik Method and system for reducing the likelihood of developing depression in an individual
US10548761B2 (en) 2011-02-04 2020-02-04 Joseph E. Kovarik Method and system for reducing the likelihood of colorectal cancer in a human being
US11844720B2 (en) 2011-02-04 2023-12-19 Seed Health, Inc. Method and system to reduce the likelihood of dental caries and halitosis
US10010568B2 (en) 2011-02-04 2018-07-03 Katherine Rose Kovarik Method and system for reducing the likelihood of a spirochetes infection in a human being
US11191665B2 (en) 2011-02-04 2021-12-07 Joseph E. Kovarik Method and system for reducing the likelihood of a porphyromonas gingivalis infection in a human being
US10111913B2 (en) 2011-02-04 2018-10-30 Joseph E. Kovarik Method of reducing the likelihood of skin cancer in an individual human being
ES2702490T3 (es) * 2011-05-03 2019-03-01 Dupont Nutrition Biosci Aps Bacterias probióticas para el tratamiento tópico de trastornos de la piel
ES2674328T3 (es) * 2011-05-06 2018-06-28 Belano Medical Ag Nuevas bacterias de ácido láctico y composiciones que las contienen
FR2998174B1 (fr) * 2012-11-21 2016-06-10 Greentech Procede de preparation d'un principe actif cosmetique ou dermatologique
FR2999932B1 (fr) 2012-12-21 2020-01-31 Société des Produits Nestlé S.A. Utilisation de microorganismes probiotiques comme agent favorisant la synthese de melanine
FR2999931A1 (fr) 2012-12-21 2014-06-27 Oreal Utilisation de microorganismes probiotiques comme agent favorisant la synthese de melanine
ES2864716T3 (es) * 2013-09-30 2021-10-14 Elc Man Llc Composición y métodos de loción acuosa para el cuidado de la piel
US11026982B2 (en) 2015-11-30 2021-06-08 Joseph E. Kovarik Method for reducing the likelihood of developing bladder or colorectal cancer in an individual human being
US11642382B2 (en) 2013-12-20 2023-05-09 Seed Health, Inc. Method for treating an individual suffering from bladder cancer
US11980643B2 (en) 2013-12-20 2024-05-14 Seed Health, Inc. Method and system to modify an individual's gut-brain axis to provide neurocognitive protection
US11826388B2 (en) 2013-12-20 2023-11-28 Seed Health, Inc. Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation
US11213552B2 (en) 2015-11-30 2022-01-04 Joseph E. Kovarik Method for treating an individual suffering from a chronic infectious disease and cancer
US11998574B2 (en) 2013-12-20 2024-06-04 Seed Health, Inc. Method and system for modulating an individual's skin microbiome
US11969445B2 (en) 2013-12-20 2024-04-30 Seed Health, Inc. Probiotic composition and method for controlling excess weight, obesity, NAFLD and NASH
US11833177B2 (en) 2013-12-20 2023-12-05 Seed Health, Inc. Probiotic to enhance an individual's skin microbiome
US12005085B2 (en) 2013-12-20 2024-06-11 Seed Health, Inc. Probiotic method and composition for maintaining a healthy vaginal microbiome
US11672835B2 (en) 2013-12-20 2023-06-13 Seed Health, Inc. Method for treating individuals having cancer and who are receiving cancer immunotherapy
US11529379B2 (en) 2013-12-20 2022-12-20 Seed Health, Inc. Method and system for reducing the likelihood of developing colorectal cancer in an individual human being
US11839632B2 (en) 2013-12-20 2023-12-12 Seed Health, Inc. Topical application of CRISPR-modified bacteria to treat acne vulgaris
CN106661543A (zh) 2014-06-17 2017-05-10 Xycrobe治疗公司 经遗传修饰的细菌和用于细菌的遗传修饰的方法
US9913800B2 (en) * 2015-04-28 2018-03-13 The Procter & Gamble Company Compositions and methods for improving skin health
US11235010B2 (en) 2015-10-07 2022-02-01 Galderma Research & Development Composition containing lactic acid bacteria and its use to treat atopic dermatitis
US10419395B2 (en) * 2015-10-23 2019-09-17 International Business Machines Corporation Routing packets in a data center network
US10933128B2 (en) 2015-11-30 2021-03-02 Joseph E. Kovarik Method and system for protecting honey bees from pesticides
US11529412B2 (en) 2015-11-30 2022-12-20 Seed Health, Inc. Method and system for protecting honey bees from pesticides
US10086024B2 (en) 2015-11-30 2018-10-02 Joseph E. Kovarik Method and system for protecting honey bees, bats and butterflies from neonicotinoid pesticides
US10675347B2 (en) 2015-11-30 2020-06-09 Joseph E. Kovarik Method and system for protecting honey bees from fipronil pesticides
US10568916B2 (en) 2015-11-30 2020-02-25 Joseph E. Kovarik Method and system for protecting honey bees, bats and butterflies from neonicotinoid pesticides
WO2017147507A1 (en) 2016-02-24 2017-08-31 Xycrobe Therapeutics, Inc. Skin probiotic formulation
FR3055799B1 (fr) 2016-09-15 2020-06-19 Basf Beauty Care Solutions France Sas Nouvelle utilisation cosmetique et/ou nutraceutique ou dermatologique d'un extrait de levure
US20180140540A1 (en) * 2016-11-23 2018-05-24 Gojo Industries, Inc. Topical cleansing composition with prebiotic/probiotic additive
RU2652277C1 (ru) * 2017-04-13 2018-04-25 Артем Михайлович Гурьев Микрокапсулы, содержащие живые микроорганизмы, и их применение
JP7208894B2 (ja) * 2017-05-23 2023-01-19 森永乳業株式会社 乳酸菌を含有する化粧料、皮膚保護剤
CN112384611B (zh) * 2018-05-23 2024-01-09 Ko生物技术有限公司 卷曲乳杆菌kbl693菌株及其用途
EP3666341B1 (de) * 2018-12-14 2022-03-23 DWI - Leibniz-Institut für Interaktive Materialien e.V. Topische formulierung in form eines pflasters, verband oder pflaster mit probiotischen bakterien und verwendung davon in einem verfahren zur behandlung oder vorbeugung von hauterkrankungen
US20200368146A1 (en) * 2019-05-22 2020-11-26 Mary Ahern Method of cosmetic preservation
CN111534447B (zh) * 2019-12-11 2022-05-24 沈阳博阳饲料股份有限公司 约氏乳杆菌及其应用
CA3183350A1 (en) 2020-06-23 2021-12-30 Thomas M. Hitchcock Probiotic skin formulations
FR3124077A1 (fr) * 2021-06-22 2022-12-23 Nanyang Technological University Utilisation d ’ un acide gras à cha î ne courte comme agent antipelliculaire

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3024318A1 (de) * 1980-06-27 1982-01-28 Chemisches Laboratorium Dr. Karl Richter GmbH, 1000 Berlin Kosmetische mittel
JPS5920220A (ja) * 1982-07-23 1984-02-01 Yakult Honsha Co Ltd 損傷皮膚創面治療剤
US5389677B1 (en) * 1986-12-23 1997-07-15 Tristrata Inc Method of treating wrinkles using glycalic acid
JPH0818995B2 (ja) * 1987-01-21 1996-02-28 株式会社アドバンス 皮膚用抗菌剤
JPH0517363A (ja) * 1991-07-11 1993-01-26 Yakult Honsha Co Ltd 抗炎症剤及びそれを含有する化粧料
KR950014592B1 (ko) * 1991-10-22 1995-12-11 주식회사태평양 화장료용 유산균제재
DE69223615T2 (de) * 1992-07-06 1998-04-09 Nestle Sa Lactobacillus Acidophilus enthaltende Antigastritis-Mittel
DK0768375T4 (da) * 1992-07-06 2002-09-16 Nestle Sa Mælkesyrebakterier
US5733568A (en) * 1993-12-03 1998-03-31 Lafor Laboratories Limited Micro-encapsulated lactobacilli for medical applications
CN1110147A (zh) * 1994-04-09 1995-10-18 山田武敏 抗变态反应组合物
AU2631695A (en) * 1994-06-17 1996-01-15 Nederlandse Organisatie Voor Toegepast- Natuurwetenschappelijk Onderzoek Tno Method for introduction of genetic material into microorganisms and transformants obtained therewith
US5656268A (en) * 1995-04-21 1997-08-12 Sorodsky; Michael Biological product
JPH092959A (ja) * 1995-06-16 1997-01-07 Yakult Honsha Co Ltd ＩｇＥ抗体産生抑制剤および抗アレルギー剤
EP0759469B1 (de) * 1995-08-07 2003-03-19 Societe Des Produits Nestle S.A. Bakteriozin
JPH09263539A (ja) * 1996-03-29 1997-10-07 Nichinichi Seiyaku Kk 抗真菌作用を有する皮膚疾患治療剤
AUPN907296A0 (en) * 1996-04-02 1996-04-26 Commonwealth Scientific And Industrial Research Organisation Biocontrol agents for use in treatment of opportunistic infections
ATE298363T1 (de) * 1996-07-09 2005-07-15 Nestle Sa Verfahren zur sprühtrocknung
FR2756181B1 (fr) * 1996-11-26 1999-03-05 Au Mont Beaute Composition cosmetique, pharmaceutique a base de culture inactivee de bacteries bifidobacterium, d'huile de menthe et d'un acide
CA2287451C (en) * 1997-04-18 2014-06-10 Sean Farmer Topical use of probiotic bacillus spores to prevent or control microbial infections
US6645506B1 (en) * 1997-04-18 2003-11-11 Ganeden Biotech, Inc. Topical compositions containing extracellular products of Pseudomonas lindbergii and Emu oil
EP0904784A1 (de) * 1997-09-22 1999-03-31 N.V. Nutricia Probiotisches Ernährungspräparat
WO1999017788A1 (en) * 1997-10-06 1999-04-15 Abbott Laboratories Composition of treatment of candidiasis
EP1364586A1 (de) * 2002-05-24 2003-11-26 Nestec S.A. Probiotika und Oraltoleranz

Also Published As

Publication number Publication date
MXPA02006222A (es) 2002-12-05
CA2395419C (en) 2010-07-06
PT1244463E (pt) 2010-09-07
DK1244463T3 (da) 2010-09-20
EP1110555A1 (de) 2001-06-27
US20160082052A1 (en) 2016-03-24
NO20022989D0 (no) 2002-06-20
KR20020068382A (ko) 2002-08-27
KR100797819B1 (ko) 2008-01-24
DE60044566D1 (de) 2010-07-29
ES2345761T3 (es) 2010-10-01
CN101385745A (zh) 2009-03-18
PL355411A1 (en) 2004-04-19
CY1111029T1 (el) 2015-06-11
AU3011801A (en) 2001-07-03
JP4828759B2 (ja) 2011-11-30
CN101385745B (zh) 2011-05-18
US20030049231A1 (en) 2003-03-13
US8685389B2 (en) 2014-04-01
EP1244463B1 (de) 2010-06-16
JP2003518070A (ja) 2003-06-03
NO20022989L (no) 2002-08-16
EP1244463A1 (de) 2002-10-02
AR030925A1 (es) 2003-09-03
CA2395419A1 (en) 2001-06-28
US20060002910A1 (en) 2006-01-05
RU2002119396A (ru) 2004-02-27
BR0016709A (pt) 2002-09-03
US9226943B2 (en) 2016-01-05
CN1434716A (zh) 2003-08-06
CN1434716B (zh) 2012-03-28
WO2001045721A1 (fr) 2001-06-28
US20140079677A1 (en) 2014-03-20

Similar Documents

Publication Publication Date Title
ATE471152T1 (de) Anti-adhäsives agens für die pathogene hautflora
DE60022540D1 (de) Befestigungselement für die haut
DE60022413D1 (de) Operationsvorrichtung für die Kornea
DE60014324D1 (de) Die pharmakologische wirkung erhöhende mittel für pestizide
DE50004664D1 (de) Endoskopartige vorrichtung, insbesondere für die notfallintubation
ATE293644T1 (de) Polyolefin und die herstellung davon
DE60005449D1 (de) Behälter und Auftragelement für Produckte für die Haut
DE60010941D1 (de) Polypropylenblockcopolymer und Verfahren für die Herstellung davon
DE10261031B4 (de) Druckgußform und Formaustauschverfahren für dieselbe
DE60045401D1 (de) Befestigungsvorrichtung für eine Bandprothese
ATE372339T1 (de) Zwischenprodukte für die herstellung von imidazo- pyridin-derivate
DE50110695D1 (de) Anlage für die Herstellung von Druckprodukten
DE60031347D1 (de) Optischer Verstärker für die C und L Banden
DE60131498T8 (de) VIRUSHÜLLENVEKTOR FüR DIE GENÜBERTRAGUNG
DE60014868D1 (de) Nahrungszusammensetzung insbesondere für die spezifische gastrointestinale reifung in frühgeborenen säugetieren
DE60141316D1 (de) Indikator für die plasmasterilisation
DE69931509D1 (de) Zubereitungen für die mundhöhle
DE60034518D1 (de) Entscheidungsfindugsgerät für die monatliche physiologische Kondition eines weiblichen Körpers
DE69828120D1 (de) Mikrokeratom für die augenchirurgie
DE69830654D1 (de) Heilmittel für die drogenabhängigkeit
DE60005597D1 (de) Band für eine Schuhpresse und Verfahren zu seiner Herstellung
DE60015898D1 (de) Band für eine Schuhpresse
DE69934484D1 (de) Flüssiges antimikrobielles feuchthaltendes mittel für die haut
DE60133688D1 (de) Hubverstelleinrichtung für eine Presse
DE60012028D1 (de) Zwischenprodukte für die herstellung von naphthyridin-3-carbonsäure-derivaten

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1244463

Country of ref document: EP